Cancer News and Research

Latest Cancer News and Research

Worldwide malaria death figures - a gross underestimate, finds latest research

According to latest research malaria kills twice as many people every year as formerly believed, taking 1.2 million lives and causing the deaths not only of babies but also older children and adults.

3 Feb 2012

Is sugar as bad as alcohol and tobacco?

According to US health experts, sugar is as damaging and addictive as alcohol or tobacco and should be regulated. The University of California team suggests new policies such as taxes are needed to control soaring consumption of sugar and sweeteners. Prof Robert Lustig argues in the opinion piece called “The Toxic Truth About Sugar” in journal Nature for major shifts in public policy.

3 Feb 2012

Urine-based biomarkers may lead to development of test for high-risk prostate cancer

Initial results of a multicenter study coordinated by researchers at Fred Hutchinson Cancer Research Center indicates that two investigational urine-based biomarkers are associated with prostate cancers that are likely to be aggressive and potentially life-threatening among men who take a "watchful waiting," or active-surveillance approach to manage their disease.

3 Feb 2012

MD Anderson study defines value in health care

A team from The University of Texas MD Anderson Cancer Center is receiving a national award for a research article tackling a question vital to the future of health care with reform regulations looming, competition growing and costs rising.

3 Feb 2012

Pertuzumab plus trastuzumab and docetaxel has advantages over current clinical gold-standard treatment

Roche/Genentech/Chugai's pertuzumab plus trastuzumab (Roche/Genentech/Chugai's Herceptin) and docetaxel (Sanofi's Taxotere, generics) will become Decision Resources' proprietary clinical gold-standard treatment for metastatic first-line HER2-positive breast cancer in 2015.

3 Feb 2012

Strategies to minimize side effects of oxaliplatin in metastatic colon cancer

The drug oxaliplatin is a major reason the prognosis for metastatic colon cancer has gone from an expected survival of several months to a couple years. Unfortunately, the drug can also carry with it debilitating neurological side effects, which generally start as the sensation of pins and needles in fingers and toes and can leave patients unable to walk or dress independently.

3 Feb 2012

Pediatricians lead statewide effort to raise awareness about childhood vaccination

Two Saint Louis University pediatricians are leading a Missouri State Medical Association statewide effort to change the way doctors respond to parents' fears of vaccines, and to raise awareness about the importance of getting children vaccinated.

3 Feb 2012

Scientists identify molecular switch that controls ATF2's dual functions

The National Cancer Institute (NCI) estimates that as many as one in 51 men and women will be diagnosed with melanoma-the deadliest form of skin cancer-at some point during their lifetimes. A research team led by Ze'ev Ronai, Ph.D. at Sanford-Burnham Medical Research Institute (Sanford-Burnham) is working to unravel the molecular mechanisms underlying the development and progression of this disease in hopes of improving prevention and treatment strategies

3 Feb 2012

NCDB: Five-year survival rates higher among cancer patients treated in SCCA

Five-year survival rates among patients treated by Seattle Cancer Care Alliance for eight types of cancer are higher than for patients treated at other academic medical centers, as well as large and small community cancer centers nationwide, according to data compiled by the National Cancer Data Base (NCDB).

3 Feb 2012

Merck Serono enters development agreement with Threshold for hypoxia-targeted drug

Merck Serono, a division of Merck KGaA, Darmstadt, Germany, today announced that a global agreement was signed with Threshold Pharmaceuticals, Inc., South San Francisco, to co-develop and commercialize TH-302, Threshold's small molecule hypoxia-targeted drug.

3 Feb 2012

AHF calls for top to bottom shake-up of management at FDA

AIDS Healthcare Foundation (AHF) today called for a top to bottom shake-up of the management at the Food and Drug Administration as well as a Congressional investigation following the publication of a Washington Post news article (1/31/12) that reported, "…the Food and Drug Administration secretly monitored the personal e-mail of a group of its own scientists and doctors after they warned Congress that the agency was approving medical devices that they believed posed unacceptable risks to patients."

3 Feb 2012

Viewpoints: Censoring flu research; Assailing Komen's move to cut Planned Parenthood funding

In December, the National Science Advisory Board for Biosecurity made an unprecedented request: it asked the editors of the journals Nature and Science not to publish certain details in two papers describing experiments in which scientists created a highly transmissible form of the deadly H5N1 influenza virus. ... Such caution, though well intentioned, is misplaced.

3 Feb 2012

Enrollment opens in sorafenib vs. radioembolization in advanced hepatocellular carcinoma trial

'SARAH' - a French national collaborative randomized controlled trial of radioembolization with yttrium-90 resin microspheres versus sorafenib in advanced hepatocellular carcinoma is now open for recruitment

3 Feb 2012

Uproar follows Komen-Planned Parenthood rift

Anti-abortion activists applaud the move, but many other women's health advocates are angered the well-known breast cancer advocacy group has opted against helping another prominent women's health organization.

3 Feb 2012

FDA intends to grant Priority Review designation for ThromboGenics' ocriplasmin

ThromboGenics NV, a biopharmaceutical company focused on developing innovative ophthalmic medicines, today announces that the FDA intended to grant its recently-submitted ocriplasmin BLA (Biological License Application) for Priority Review.

3 Feb 2012

Small molecules at cell's membrane enable cell movement

Cell biologists at Johns Hopkins have identified key steps in how certain molecules alter a cell's skeletal shape and drive the cell's movement.

3 Feb 2012

Molecular subtypes of lung cancer manifest as different diseases

Different kinds of lung cancer behave in different ways, suggesting they are fundamentally different diseases. According to a University of Colorado Cancer Center study published in Cancer, the official journal of the American Cancer Society, different subgroups of non-small cell lung cancer (NSCLC) show distinct patterns of spread in the body.

3 Feb 2012

The Mann Group and MannKind enter stock purchase agreement

MannKind Corporation today announced that it has entered into a purchase agreement with The Mann Group LLC, an entity controlled by MannKind's chief executive officer and principal stockholder, Alfred E. Mann, for the sale of shares of its common stock to The Mann Group.

3 Feb 2012

Immune cells from healthy individuals effectively kill cancer cells

Immune cells from healthy individuals can be the new immune cure for cancer. This treatment can kill cancer cells without destroying neighbouring cells. The hope is to eradicate cancer for ever.

3 Feb 2012

Caffeine consumption reduces risk of advanced fibrosis in NAFLD patients

Caffeine consumption has long been associated with decreased risk of liver disease and reduced fibrosis in patients with chronic liver disease. Now, newly published research confirms that coffee caffeine consumption reduces the risk of advanced fibrosis in those with nonalcoholic fatty liver disease (NAFLD).

3 Feb 2012

Cancer News and Research

Latest Cancer News and Research

Worldwide malaria death figures - a gross underestimate, finds latest research

Is sugar as bad as alcohol and tobacco?

Urine-based biomarkers may lead to development of test for high-risk prostate cancer

MD Anderson study defines value in health care

Pertuzumab plus trastuzumab and docetaxel has advantages over current clinical gold-standard treatment

Strategies to minimize side effects of oxaliplatin in metastatic colon cancer

Pediatricians lead statewide effort to raise awareness about childhood vaccination

Scientists identify molecular switch that controls ATF2's dual functions

NCDB: Five-year survival rates higher among cancer patients treated in SCCA

Merck Serono enters development agreement with Threshold for hypoxia-targeted drug

AHF calls for top to bottom shake-up of management at FDA

Viewpoints: Censoring flu research; Assailing Komen's move to cut Planned Parenthood funding

Enrollment opens in sorafenib vs. radioembolization in advanced hepatocellular carcinoma trial

Uproar follows Komen-Planned Parenthood rift

FDA intends to grant Priority Review designation for ThromboGenics' ocriplasmin

Small molecules at cell's membrane enable cell movement

Molecular subtypes of lung cancer manifest as different diseases

The Mann Group and MannKind enter stock purchase agreement

Immune cells from healthy individuals effectively kill cancer cells

Caffeine consumption reduces risk of advanced fibrosis in NAFLD patients

Industry Focus eBook - Oncology (1st Edition) eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Cancer News and Research

Latest Cancer News and Research

Industry Focus eBook - Oncology (1st Edition) eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in